Selection of lung cancer treatment should be based on tumour characteristics, physiological reserves and preferences of the patient. Our aims were to identify and quantify other factors associated with treatment received. Lung cancer patient data from 2002 to 2011 were obtained from the national population-based Cancer Registry of Norway, Statistics Norway and the Norwegian Patient Register. Multivariable logistic regression examined whether year of diagnosis, age, sex, education, income, health trust, smoking status, extent of disease, histology and comorbidities were associated with choice of treatment; surgery or radical or palliative radiotherapy, within 1 year of diagnosis. Among the 24,324 lung cancer patients identified, the resection rate remained constant while the proportion of radical radiotherapy administered increased from 8.6 to 14.1%. Older patients, those with lower household incomes and certain health trusts were less likely to receive any treatment. Lower education and the male gender were identified as negative predictors for receiving surgery. Smoking history was positively associated with both radical and palliative radiotherapy, while comorbidity and symptoms were independently associated with receiving surgery and palliative radiotherapy. Although Norway is a highly egalitarian country with a free, universal healthcare system, this study indicates that surgery and radical and palliative radiotherapy were under-used among the elderly, those with a lower socioeconomic status and those living in certain health trusts.
Selection of lung cancer treatment should be based on tumour characteristics, physiological reserves and preferences of the patient. Our aims were to identify and quantify other factors associated with treatment received. Lung cancer patient data from 2002 to 2011 were obtained from the national population-based Cancer Registry of Norway, Statistics Norway and the Norwegian Patient Register. Multivariable logistic regression examined whether year of diagnosis, age, sex, education, income, health trust, smoking status, extent of disease, histology and comorbidities were associated with choice of treatment; surgery or radical or palliative radiotherapy, within 1 year of diagnosis. Among the 24,324 lung cancer patients identified, the resection rate remained constant while the proportion of radical radiotherapy administered increased from 8.6 to 14.1%. Older patients, those with lower household incomes and certain health trusts were less likely to receive any treatment. Lower education and the male gender were identified as negative predictors for receiving surgery. Smoking history was positively associated with both radical and palliative radiotherapy, while comorbidity and symptoms were independently associated with receiving surgery and palliative radiotherapy. Although Norway is a highly egalitarian country with a free, universal healthcare system, this study indicates that surgery and radical and palliative radiotherapy were under-used among the elderly, those with a lower socioeconomic status and those living in certain health trusts.
According to Norwegian guidelines, lung cancer treatment should be based on extent of disease (EOD), tumor histology, comorbidities, performance status and preferences of the patient. 1 Surgical resection is considered a prerequisite for the cure of lung cancer, but a benefit has only been shown for patients with localized disease, that is, disease that does not extend beyond the intrapulmonary or hilar lymph nodes.
Stereotactic radiotherapy has recently become an alternative for selected patients. 2, 3 If a patient is deemed ineligible for surgical treatment due to EOD or significant comorbidities, radiotherapy and/or chemotherapy can be offered. For patients with mediastinal lymph node metastasis, this combination is offered with curative intent, while for patients whose tumours have spread beyond the lung and mediastinum, in the majority of patients, palliative radiotherapy and/ or chemotherapy are offered for symptom relief, to slow disease progression and improve medium term survival. Likelihood of both receiving surgical treatment and radiotherapy as treatment for lung cancer has previously been shown to be affected by factors not mentioned in guidelines. A number of studies have found that socioeconomic status (SES) and/or place of residence may influence the likelihood of receiving surgical treatment. [4] [5] [6] [7] [8] However, the influence of SES on radiotherapy remains inconclusive. 4, [9] [10] [11] Previous studies have been unable to examine the association between lung cancer treatment and factors not mentioned in the guidelines, using individual measures of SES. To date there has been no population-based study examining radiotherapy as a treatment for lung cancer, stratified by treatment intention (i.e., radical and palliative radiotherapy). 6 If factors other than EOD, histology and presence of comorbidities are found to be independently associated with treatment received, it may suggest that some subgroups are overor under-treated. This study is unique in so far as it is a nationwide population-based study that examines and quantifies the association between nonguideline specified factors and surgical treatment and radical radiotherapy or palliative radiotherapy for lung cancer patients.
Material and Methods

Cancer registry of Norway
All hospitals, pathology laboratories and general practitioners in Norway must report all newly diagnosed malignant neoplasms to the Cancer Registry of Norway (CRN). The CRN also receives death certificates from the Cause of Death Registry. Using the personal identification number assigned to each Norwegian citizen, the CRN is linked monthly to the National Population Register to update vital status (death or emigration) and yearly to the National Patient Register to ensure completeness of cancer cases. The CRN contains clinical reports from hospitals, which include individual information on surgical treatment, smoking status and symptoms. However, smoking status and symptoms are only available for patients diagnosed in 2004-2010. The CRN also contains patient-identifiable radiotherapy data, which it receives annually from all radiotherapy centres in Norway.
All cases with malignant neoplasm of bronchus and lung (International Classification of Diseases, Revision 10 (ICD-10) code C34) diagnosed between 1 January 2002 and 31 December 2011 and recorded in the CRN were eligible for inclusion in this study. The quality, comparability, completeness, validity and timeliness of the data in the CRN are high, with a 96.9% estimated completeness for lung cancer. 12 
Classification of variables
Year and age at diagnosis, sex, smoking status, symptoms, EOD and histology were extracted from the CRN, as was information on surgical treatment and radiotherapy. 13 Duration of symptoms was defined as the number of days from when the first symptom occurred to date of diagnosis. EOD was grouped into localized, regional or metastatic, according to the condensed tumor, node, metastasis (TNM) status.
14 Before 2008, EOD was coded as unknown if it was based solely on the pathology report (i.e., no valid clinical notification) and there was no information about metastases at the time of diagnosis. After 2008, these cases were coded as localized if they received curative surgery, but to avoid bias in this study, we classified all post-2008 information about EOD as unknown. Treatment intention for radiotherapy was categorized as radical (including curative, local control and prophylactic) or palliative. 15 When treatment intention was missing (5.3% of patients), it was assigned based on the radiotherapy dose, in accordance with the national guidelines available during the study period. Small-cell carcinoma patients receiving doses of 42 Gy and <42 Gy were categorized as radical and palliative, respectively. Nonsmall cell carcinoma patients were categorized as radical if they received doses of 60 Gy, otherwise radiotherapy was classified as palliative. If the total dose given was 45 Gy and given in 3 fractions, it was defined as stereotactic and classified as curative.
In 2011, Norway consisted of 21 health trusts which are responsible for general healthcare treatment and management of all patients residing in its geographical catchment area. The study variable denoting health service region was based on the patients' place of residence, independent of where the patient was treated. Due to centralization, the number of hospitals performing surgery has decreased. 16 In 2002, there were 14 health trusts that had hospitals performing surgery and 7 that were providing radiotherapy, while the comparable numbers in 2011 were 7 (Ahus, OUS, Helse Stavanger, Helse Bergen, St.Olavs Hospital, Nordlandssykehuset and UNN) and 9 (OUS, Innlandet, Sørlandet, Helse Stavanger, Helse Bergen, Helse Møre og Romsdal, St.Olavs Hospital, Nordlandssykehuset and UNN). Data on the highest education level achieved and household income during the year before lung cancer diagnosis were obtained through linkage with Statistics Norway. Data on household income was only available after 2004. The cutpoints were set at the 33rd (low) and 66th (high) percentiles with an intermediate group between these cut-points and were redefined every year to account for increasing income over time.
Comorbidity information was measured using a modified version of the Charlson comorbidity index (CCI), which is constructed by using diagnostic codes (ICD-10) from hospitalizations within one year prior to and including, the date of diagnosis. A score is determined for each of a patient's recorded comorbid diseases based on its severity and the What's new? According to Norwegian guidelines, lung cancer treatment should be based on extent of disease, tumour histology, comorbidities, performance status and preferences of the patient. Here, the authors present the first nationwide population-based study to examine and quantify the association between nonguideline-specified factors and surgical treatment and radical radiotherapy or palliative radiotherapy for lung cancer patients. The results suggest that even in a highly egalitarian country with a free, universal healthcare system such as Norway, lung cancer patients with low socioeconomic status, advanced age and living in certain areas are less likely to receive surgery, radical radiotherapy and palliative radiotherapy.
combination of these scores results in a modified CCI. Comorbidity information is only available for patients diagnosed after 1 January 2009 and it is collected from the Norwegian Patient Register which only contains personidentifiable data from January 2008 onwards. The index was categorized into: "no hospital admissions before lung cancer diagnosis" (CCI 5 21), low (CCI 5 0), intermediate (CCI 5 1, 2) and high (CCI 3).
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Data on chemotherapy were not available; hence "no treatment" refers to patients who received neither surgery nor radiotherapy.
Statistical analysis
Multiple imputation is a statistical method that uses available data to model the likely distribution of missing data and was used to handle incomplete data on education, income, smoking status, symptoms, EOD and histology. The imputation model was run 30 times using the mi impute chained command in STATA 13.1.
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Likelihood ratio tests were performed using complete case data (i.e., excluding patients with missing information), to assess which variables to include in the final models. Multivariable logistic regression models examined possible predictors of the first treatment received within 1 year of diagnosis. All models included year of diagnosis, age, sex, education, income, place of residence (i.e., health trust), EOD and histology. The same analysis, stratified by histology, was performed to find predictors for receiving treatment. Since SCLC patients very seldom undergo surgery, the outcomes considered here were only radical and palliative radiotherapy. To estimate the proportion of patients experiencing different treatments, a competing risk model was created. 21 For all treatment modalities, multivariable subanalyses were performed for patients diagnosed in 2004-2010 and 2009-2011 , to be able to account for smoking and comorbidity, respectively. Statistical significance (p < 0.05) of the individual explanatory variables was obtained from Wald tests. The correlation between the proportions of patients treated with radical and palliative radiotherapy between patients residing in different health trusts was measured using Pearson's correlation coefficient. To measure how the changes in treatment rates affect the odds of receiving treatment between all health trusts over time, we measured the median difference between the estimated odds ratios (OR) for each health trust and the national average (OR 51). This is calculated in 2002-2006 and 2007-2011 , for all three treatment modalities.
Results
We identified 25,082 patients with a diagnosis of primary lung cancer in 2002-2011. We excluded 29 (0.1%) with a registered date of diagnosis or surgical treatment after the date of death and 8 (0.03%) due to surgery occurring outside Norway. An additional 151 (0.6%) patients diagnosed through autopsy, 524 (2.1%) registered solely based on death certificates and 46 (0.2%) registered with "other specified histologies" (80.4% of which were sarcoma) were also excluded. The final study sample was 24,324 lung cancer patients. The proportion of C33-34 patients with a histologically verified diagnosis in 2002-2011 was 78.7%.
The proportion of patients with "no treatment" decreased from 50.0 to 38.7% over the study period and ranged overall between 36.1 and 54.6% across health trusts. This decrease was offset by a corresponding increase in radical and palliative radiotherapy, while the proportion of patients who received surgical treatment remained fairly constant (Table  1) . A higher proportion of patients with high education and/ or high household income were treated with surgery or radiotherapy ( Table 1) .
Within 1 year of diagnosis, 16.5, 9.7 and 30.7% of patients were treated with surgery, radical radiotherapy and palliative radiotherapy, respectively (Fig. 1) . While the proportion treated with surgery and radical radiotherapy reached a plateau after 3-4 months, this pattern was not seen for patients treated with palliative radiotherapy (Fig. 1 ). There was a small increase over time in the proportion of patients initially treated with radical or palliative radiotherapy (Fig. 2) .
Surgery
Men were less likely than women to undergo surgery (odds ratio [OR] 5 0.84, 95% confidence interval [CI]:0.77-0.93; Table 2 ). Patients with high education or high household income were more likely to undergo surgery than those with low education or low household income after adjusting for case mix [OR 5 1.28, 95% CI: (1.08-1.51) and OR 51.66, 95% CI: (1.43-1.94), respectively] ( Table 2) . Across health trusts the OR for surgery varied from 0.74 to 1.63 when compared with the national average (Fig. 3) . The median differences in OR between health trusts were calculated to be 0.28 in the first period and 0.29 in the second period.
The inclusion of symptoms, smoking or comorbidity in the multivariable model had only a minimal effect on the ORs for the other explanatory variables (data not shown). Current and former smokers were indicated to have a reduced odds of receiving surgery compared with never smokers; however the results did not achieve statistical significance (Table 2) . Patients with "no hospital admissions before lung cancer diagnosis" were less likely to undergo surgery than patients with low comorbidities (OR 5 0.53, 95% CI: 0.30-0.93), although this difference was non-significant when presence and duration of symptoms were included in the model (OR 5 1.06, 95% CI: 0.44-2.52).
Radical radiotherapy
The odds of receiving radical radiotherapy increased over time and decreased with increasing age (Table 2 ). While 0.7% of patients were treated with stereotactic radiotherapy during the study period, 2.4% received it in 2011 (data not shown). High household income was associated with increased odds of receiving radical radiotherapy (OR 5 1.35, 95% CI: 1.15-1.58; Table 2 ). Compared with the national 
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Nilssen et al. average, the OR for receiving radical radiotherapy varied across health trusts (from 0.56 to 1.50; Fig. 3 ). The Pearson's correlation coefficient comparing the proportions of patients treated with radical and palliative radiotherapy between patients residing in different health trusts was 0.22 (95%CI:
20.23 -0.60). The median differences in OR between health trusts were calculated to be 0.37 in the first period and 0.36 in the second period. Compared with never smokers, current and former smokers had at least 75% greater odds of receiving radical 
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Palliative radiotherapy
Patients aged 80 years were less likely than those aged 50-59 years to receive palliative radiotherapy (OR 5 0.37, 95% CI: 0.33-0.41; Table 2 ). Patients with a high household income were more likely to receive palliative radiotherapy than those with low income (OR 5 1.42, 95% CI: 1.29-1.57). Figure 3 shows geographical differences for receiving palliative radiotherapy, with ORs ranging from 0.64 to 1.47 across the health trusts. The median differences in OR between health trusts were calculated to be 0.23 in the first period and 0.28 in the second period.
Former smokers had increased odds of receiving palliative radiotherapy compared to never smokers [OR 5 1.33, 95% CI: (1.12-1.58)] and a high comorbidity score was negatively associated with palliative radiotherapy (OR 5 0.45, 95% CI: 0.34-0.58 for high vs. low comorbidity; Table 2 ). Including smoking and comorbidity only marginally affected the estimated ORs for the other explanatory variables (data not shown). The odds for receiving palliative radiotherapy differed between NSCLC and SCLC patients over time (p-value < 0.01), with an increase only observed among SCLC patients (data not shown). The odds for receiving palliative radiotherapy had a steeper trend with higher levels of education for SCLC patients compared with NSCLC patients (SCLC: intermediate vs. 
Discussion
Together with the criteria for treatment specified in the national guidelines (EOD, histology and comorbidity), we found that education, household income and place of residence (i.e., health trust) were independent predictive factors for receiving surgical treatment among lung cancer patients in Norway in 2002-2011. We also found that age, household income and health trust were independently associated with both radical and palliative radiotherapy. Furthermore, smokers were less likely than nonsmokers to receive surgery, but more likely to receive radical radiotherapy.
While it is well-known that the guideline factors are predictors for treatment, our finding that education and income are positively associated with receiving surgical treatment for lung cancer is rather surprising in a country with free, universal healthcare. However, a positive association between income and surgery has also been reported in England, where they have universal healthcare as well. 6, 9 Only one other study is directly comparable as it also uses individual measures of SES to investigate treatment among lung cancer patients. 22 This study used education as a proxy for SES and reported that higher education was associated with an almost 2-fold increase in the likelihood of receiving surgical treatment. As lower SES is often associated with poorer general health and greater smoking prevalence, these factors may also contribute to the observed differences in surgical treatment for lung cancer. 23 However, our results coincide with previous research that reduced general health in lower SES groups does not explain observed differences in the likelihood of receiving surgery. 9 High household income was also associated with increased odds of receiving both radical and palliative radiotherapy. A recent systematic review showed that countries with nonuniversal healthcare, such as the USA, experience SES differences with respect to radiotherapy while most of the studies in countries with universal healthcare, such as Norway and other European countries did not. 4 The one study that used individual measures of education to categorise SES found a pattern similar to ours, although it did not distinguish between radical and palliative radiotherapy. 22 A possible explanation for the differences in results is the use of individual measures versus area-based measures of SES. Differences in smoking consumption and performance status between the household income categories may also explain varying radiotherapy use. 23 It can be argued that education and income are both proxies for SES and that their corresponding estimates often measure the same effect. However, previous studies, including our study, argue that education and income measure different aspects of SES, and that, they should both be treated as independent predictors for treatment. 24, 25 Place of residence was found to be an independent predictor for receipt of each of the three treatment modalities. The geographical differences we found coincide with other international studies. 7, [26] [27] [28] [29] In our study, when the location where surgery was performed (within or outside of the health trust) was included in the model, it did not affect the differences by health trust (data not shown). The observed geographical differences for radiotherapy were found for both radical and palliative intentions. When we explored differences in the odds for treatment between health trusts over time, there was no change for surgery and radical radiotherapy, however a small increase was observed for palliative radiotherapy.
We found that men had a 15% reduced odds of receiving surgery compared with women. A Danish study 30 reported the opposite result, while other studies reported no significant differences between the sexes. 5, 9, 26, 31 A possible explanation for these results could be historical differences in smoking habits, although this seems unlikely as the difference persisted after adjustment for smoking status. Another possibility could be that as men tend to smoke more heavily than women, they present with more advanced stages of lung cancer, more comorbidities and poorer performance status, making surgery less viable. 32 Increasing age was associated with a reduced likelihood of receiving any of the treatment modalities. Other studies have also reported that the elderly have a reduced chance of receiving palliative radiotherapy. [33] [34] [35] [36] [37] It is possible that the elderly are being evaluated for radiotherapy solely based on their age, instead of all the criteria specified in treatment guidelines, and hence are being under-treated. The elderly also have poorer performance status hence lower life expectancy which might explain some of the lower use of treatment.
Our results also showed that current and former smokers were less likely to undergo surgery and more likely to receive radical and palliative radiotherapy compared to never smokers. In addition, current and former smokers had more comorbidities than never smokers (data not shown), which might explain why never smokers were more likely to receive surgery, since high comorbidity is a contra-indication for surgery.
We were only able to adjust for EOD and comorbidities through condensed TNM status and CCI, respectively, thus the observed sex and smoking difference might be a result of residual confounding of EOD and comorbidity.
Patients with "no hospital admissions before lung cancer diagnosis" had 50% lower odds for undergoing surgery, and 80% higher odds for undergoing radical radiotherapy when compared to patients with low comorbidity. Within this small group of patients with "no hospital admissions before lung cancer diagnosis," a higher proportion had symptoms, but the symptom duration was shorter. This could indicate that these patients generally had more aggressive tumors, and thus were ineligible for surgery. One could also speculate that these patients may choose to avoid hospitals, in general, and therefore are less likely to undergo surgery. In line with other studies, we also found that general health as measured by the CCI was negatively associated with receiving palliative radiotherapy. 35, 37 This could indicate that patients with a number of comorbidities have a shorter life expectancy and do not live long enough to receive palliative radiotherapy or they are too weak to endure it.
This study has some limitations. We had no information on receipt of chemotherapy, and as nearly half of all patients are diagnosed at a stage that calls for chemotherapy, this information would have provided a more complete picture of the treatment patterns in the Norwegian population. Moreover, detailed TNM status was not available for unresected lung cancer patients and we did not have information on comorbidity and smoking for the whole study period. Finally, we have no information about performance status, which is important when considering patients' treatment options, and which may have been useful for explaining the results on smoking status, comorbidity and symptoms. Despite these limitations, this study provides unique and important information on lung cancer treatment in Norway through the use of complete information on surgery and radiotherapy classified by treatment intent, and of individual-level information on education and income. The study's population-based design and the use of national, comprehensive, high-quality data provide results that are widely representative.
Norway is considered to be an egalitarian society, with a GINI-index in the first quintile that varied between 26.5 and 30.2 in 2002-2011. 38 In such a society, where by law all citizens have equal access to the healthcare system regardless of their social class or place of residence, the differences in the likelihood of receiving surgery and radiotherapy that we found may indicate the existence of social inequality in health services depending on where one lives in the country. One could speculate that patients with high education or high income are better informed about their treatment options, and may be more active in the decision making process with their doctor.
In conclusion, this study showed that even in a country with a free, universal healthcare system, lung cancer patients with low SES, advanced age and living in certain areas were less likely to receive surgery, radical radiotherapy and palliative radiotherapy.
